Catelani Michael 4
4 · Anixa Biosciences Inc · Filed Jan 16, 2024
Insider Transaction Report
Form 4
Catelani Michael
President, COO & CFO
Transactions
- Award
Employee Stock Option (Right to Buy)
2024-01-12+350,000→ 350,000 totalExercise: $4.39Exp: 2034-01-12→ Common Stock (350,000 underlying)
Footnotes (2)
- [F1]Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
- [F2]The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2024.